BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16775339)

  • 1. Role of maternal autologous neutralizing antibody in selective perinatal transmission of human immunodeficiency virus type 1 escape variants.
    Dickover R; Garratty E; Yusim K; Miller C; Korber B; Bryson Y
    J Virol; 2006 Jul; 80(13):6525-33. PubMed ID: 16775339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing antibody and perinatal transmission of human immunodeficiency virus type 1. New York City Perinatal HIV Transmission Collaborative Study Group.
    Hengel RL; Kennedy MS; Steketee RW; Thea DM; Abrams EJ; Lambert G; McDougal JS
    AIDS Res Hum Retroviruses; 1998 Apr; 14(6):475-81. PubMed ID: 9566549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing antibodies and viral characteristics in mother-to-child transmission of HIV-1.
    Scarlatti G; Leitner T; Hodara V; Halapi E; Rossi P; Albert J; Fenyö EM
    AIDS; 1993 Nov; 7 Suppl 2():S45-8. PubMed ID: 8161445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal Neutralization-Resistant Virus Variants Do Not Predict Infant HIV Infection Risk.
    Milligan C; Omenda MM; Chohan V; Odem-Davis K; Richardson BA; Nduati R; Overbaugh J
    mBio; 2016 Feb; 7(1):e02221-15. PubMed ID: 26838723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal but Not Infant Anti-HIV-1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity.
    Ghulam-Smith M; Olson A; White LF; Chasela CS; Ellington SR; Kourtis AP; Jamieson DJ; Tegha G; van der Horst CM; Sagar M
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum.
    Dickover RE; Garratty EM; Plaeger S; Bryson YJ
    J Virol; 2001 Mar; 75(5):2194-203. PubMed ID: 11160723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Features of HIV-1 that could influence maternal-child transmission.
    Kliks SC; Wara DW; Landers DV; Levy JA
    JAMA; 1994 Aug; 272(6):467-74. PubMed ID: 8040983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.
    Dickover RE; Garratty EM; Herman SA; Sim MS; Plaeger S; Boyer PJ; Keller M; Deveikis A; Stiehm ER; Bryson YJ
    JAMA; 1996 Feb; 275(8):599-605. PubMed ID: 8594240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing antibody escape during HIV-1 mother-to-child transmission involves conformational masking of distal epitopes in envelope.
    Goo L; Milligan C; Simonich CA; Nduati R; Overbaugh J
    J Virol; 2012 Sep; 86(18):9566-82. PubMed ID: 22740394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity and Function of Maternal HIV-1-Specific Antibodies at the Time of Vertical Transmission.
    Doepker LE; Simonich CA; Ralph D; Shipley MM; Garrett M; Gobillot T; Vigdorovich V; Sather DN; Nduati R; Matsen FA; Overbaugh JM
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic bottleneck in vertical transmission of subtype C HIV-1 is not driven by selection of especially neutralization-resistant virus from the maternal viral population.
    Russell ES; Kwiek JJ; Keys J; Barton K; Mwapasa V; Montefiori DC; Meshnick SR; Swanstrom R
    J Virol; 2011 Aug; 85(16):8253-62. PubMed ID: 21593171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations that confer resistance to broadly-neutralizing antibodies define HIV-1 variants of transmitting mothers from that of non-transmitting mothers.
    Kumar A; Giorgi EE; Tu JJ; Martinez DR; Eudailey J; Mengual M; Honnayakanahalli Marichannegowda M; Van Dyke R; Gao F; Permar SR
    PLoS Pathog; 2021 Apr; 17(4):e1009478. PubMed ID: 33798244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of Neutralizing Responses against Autologous Virus in Maternal HIV Vaccine Trials.
    Hompe ED; Mangold JF; Kumar A; Eudailey JA; McGuire E; Haynes BF; Moody MA; Wright PF; Fouda GG; Giorgi EE; Gao F; Permar SR
    mSphere; 2020 Jun; 5(3):. PubMed ID: 32493720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syncytium-inhibiting and neutralizing activity in maternal sera fail to prevent vertical transmission of human immunodeficiency virus type 1.
    Bal AK; Miller G; Viscarello R; Andiman WA
    Pediatr Infect Dis J; 1996 Apr; 15(4):315-20. PubMed ID: 8866800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates.
    Scarlatti G; Albert J; Rossi P; Hodara V; Biraghi P; Muggiasca L; Fenyö EM
    J Infect Dis; 1993 Jul; 168(1):207-10. PubMed ID: 8515110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses.
    Tu JJ; Kumar A; Giorgi EE; Eudailey J; LaBranche CC; Martinez DR; Fouda GG; Moreau Y; Thomas A; Montefiori D; Gao F; Sagar M; Permar SR
    J Virol; 2022 Jun; 96(11):e0023122. PubMed ID: 35536018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission.
    Permar SR; Fong Y; Vandergrift N; Fouda GG; Gilbert P; Parks R; Jaeger FH; Pollara J; Martelli A; Liebl BE; Lloyd K; Yates NL; Overman RG; Shen X; Whitaker K; Chen H; Pritchett J; Solomon E; Friberg E; Marshall DJ; Whitesides JF; Gurley TC; Von Holle T; Martinez DR; Cai F; Kumar A; Xia SM; Lu X; Louzao R; Wilkes S; Datta S; Sarzotti-Kelsoe M; Liao HX; Ferrari G; Alam SM; Montefiori DC; Denny TN; Moody MA; Tomaras GD; Gao F; Haynes BF
    J Clin Invest; 2015 Jul; 125(7):2702-6. PubMed ID: 26053661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants.
    Fouda GG; Mahlokozera T; Salazar-Gonzalez JF; Salazar MG; Learn G; Kumar SB; Dennison SM; Russell E; Rizzolo K; Jaeger F; Cai F; Vandergrift NA; Gao F; Hahn B; Shaw GM; Ochsenbauer C; Swanstrom R; Meshnick S; Mwapasa V; Kalilani L; Fiscus S; Montefiori D; Haynes B; Kwiek J; Alam SM; Permar SR
    Retrovirology; 2013 Jan; 10():3. PubMed ID: 23305422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal antibodies to HIV-1 envelope domains: No correlation with HIV-1 vertical transmission in patients from Argentina.
    Calarota SA; Libonatti OV
    Scand J Immunol; 2000 Sep; 52(3):292-7. PubMed ID: 10972906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal humoral factors associated with perinatal human immunodeficiency virus type-1 transmission in a cohort from Kigali, Rwanda, 1988-1994.
    Tranchat C; Van de Perre P; Simonon-Sorel A; Karita E; Benchaïb M; Lepage P; Desgranges C; Boyer V; Trépo C
    J Infect; 1999 Nov; 39(3):213-20. PubMed ID: 10714798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.